Biotechnology · Healthcare
Board Member
2022-10-03–present
Board Member
Regeneron Pharmaceuticals, Inc. (REGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get REGN alertsCraig B. Thompson, M.D. is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN) since October 3, 2022. Regeneron Pharmaceuticals, Inc. reported in an 8-K filed October 3, 2022 that Craig B. Thompson, M.D. was appointed director, effective October 3, 2022. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.
“On October 3, 2022, the board of directors (the "Board") of Regeneron Pharmaceuticals, Inc. (the "Company") elected Craig B. Thompson, M.D. as a director.”
2022-10-03–present
Biotechnology · Healthcare
Board Member
2022-10-03–present